Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Ginkgo Bioworks plans a reverse stock split of 1-for-20 to 1-for-40. Shareholders will vote on this plan on August 14, 2024. The split aims to prevent delisting from the NYSE due to low share price. DNA stock has fallen 23.4% recently, down 83% this year.
- Ginkgo Bioworks plans a reverse stock split of 1-for-20 to 1-for-40.
- Shareholders will vote on this plan on August 14, 2024.
- The split aims to prevent delisting from the NYSE due to low share price.
- DNA stock has fallen 23.4% recently, down 83% this year.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.